01 16BOEHRINGER INGELHEIM
01 1610596120
01 16Blank
01 16Y
01 162032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208658
Patent Use Code : U-2792
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2776
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208658
Patent Use Code : U-2775
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2790
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2776
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208658
Patent Use Code : U-2792
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208658
Patent Use Code : U-2775
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2776
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208658
Patent Use Code : U-2775
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10596120
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2790
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
